Shareholder Class Actions

     CIT Group, Jeffrey Peek and Joseph Leone artificially inflated the value of CIT’s stock by making false and misleading statements to investors, shareholders claim in Manhattan Federal Court.




     
     A class action in Delaware Chancery Court seeks to stop Genentech officers from accepting Roche Holdings’ bid to buy the outstanding shares of Genentech for the allegedly opportunistic prices of $89 a share, when analysts value the stock at more than $100 per share.

%d bloggers like this: